​

Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Axsome Therapeutics Ownership Summary

Axsome Therapeutics is owned by 15.93% institutional investors, 15.70% insiders, and 68.37% retail investors. Vanguard group is the largest institutional shareholder, holding 8.46% of AXSM shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.69% of its assets in Axsome Therapeutics shares.

AXSM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAxsome Therapeutics15.93%15.70%68.37%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group4.18M8.46%$507.74M
Blackrock funding, inc. /de3.79M7.67%$460.41M
Blackrock3.30M6.96%$265.65M
Wellington management group llp1.33M2.70%$162.08M
Rtw investments, lp1.12M2.26%$135.89M
Macquarie group1.08M2.19%$131.72M
Price t rowe associates inc /md/1.04M2.10%$126.00M
Geode capital management997.70K2.02%$121.19M
Invesco990.56K2.00%$120.30M
State street942.96K1.91%$114.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management670.88K52.34%$81.48M
Svb capital management33.85K12.95%$4.11M
Fairmount funds management815.18K8.91%$99.00M
Tri locum partners lp292.14K8.16%$35.48M
Pfm health sciences, lp530.33K4.95%$64.41M
Iridian asset management llc/ct83.55K3.99%$10.15M
Ghost tree capital150.00K3.78%$12.07M
Nationale-nederlanden powszechne towarzystwo emerytalne326.32K3.06%$39.63M
Deep track capital, lp900.00K3.05%$109.31M
First turn management152.61K2.78%$18.53M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp1.33M0.03%609.52K
Price t rowe associates inc /md/1.04M0.01%424.70K
Invesco990.56K0.02%419.01K
Norges bank403.03K0.00%403.03K
Marshall wace, llp378.02K0.05%321.31K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il486.76K2.40%-1.20M
Ra capital management---1.00M
Rtw investments, lp1.12M1.67%-398.02K
Ubs group212.45K0.00%-383.00K
1832 asset management---363.20K

New Positions

HolderShares% AssetsChangeValue
Norges bank403.03K0.00%403.03K$34.10M
Vestal point capital, lp150.00K0.82%150.00K$18.22M
Summit financial77.54K0.14%77.54K$9.42M
Scout investments69.56K0.15%69.56K$5.60M
Stanley-laman group17.50K0.30%17.50K$2.13M

Sold Out

HolderChange
Financial gravity asset management-1.00
Geowealth management-5.00
Allspring global investments-9.00
Capital performance advisors llp-10.00
Nelson, van denburg & campbell wealth management group-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025146-59.22%7,876,625-78.56%150.29%77-62.44%34-60.47%
Jun 30, 2025365-3.18%37,827,2692.24%761.33%2069.57%89-25.21%
Mar 31, 202519-94.14%7,027,292-81.11%140.24%8-94.97%9-90.00%
Dec 31, 20243193.57%37,149,265-2.97%771.22%15315.04%90-1.10%
Sep 30, 202430712.45%38,233,493-6.12%791.08%13115.93%93-1.06%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.31M2.69%114.89K
Vanguard Total Stock Mkt Idx Inv1.24M2.48%-25.86K
iShares Russell 2000 ETF973.92K1.95%-
Vanguard Small Cap Index955.65K1.92%-7.08K
Macquarie Small Cap Core I651.89K1.31%-48.97K
Delaware Small Cap Core I579.64K1.21%-3.59K
Vanguard Small Cap Growth Index Inv539.73K1.08%-181.00
Bellevue Healthcare Ord506.57K1.06%506.57K
Vanguard Institutional Extnd Mkt Idx Tr444.16K0.89%-196.42K
Fidelity Small Cap Index405.99K0.81%32.79K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 02, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$7.12M
Dec 03, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$2.96M
Dec 04, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$1.56M
Nov 05, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$2.93M
Nov 04, 2025TABUTEAU HERRIOT Chief Executive OfficerSell$6.75M

Insider Transactions Trends

DateBuySell
2025 Q4-9
2025 Q3313
2025 Q2-11
2025 Q1-2
2024 Q4--

AXSM Ownership FAQ

Who Owns Axsome Therapeutics?

Axsome Therapeutics shareholders are primarily institutional investors at 15.93%, followed by 15.70% insiders and 68.37% retail investors. The average institutional ownership in Axsome Therapeutics's industry, Biotech Stocks , is 45.22%, which Axsome Therapeutics falls below.

Who owns the most shares of Axsome Therapeutics?

Axsome Therapeutics’s largest shareholders are Vanguard group (4.18M shares, 8.46%), Blackrock funding, inc. /de (3.79M shares, 7.67%), and Blackrock (3.3M shares, 6.96%). Together, they hold 23.09% of Axsome Therapeutics’s total shares outstanding.

Does Blackrock own Axsome Therapeutics?

Yes, BlackRock owns 6.96% of Axsome Therapeutics, totaling 3.3M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 265.65M$. In the last quarter, BlackRock increased its holdings by 104.5K shares, a 3.27% change.

Who is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested, with 52.34% of its assets in 670.88K Axsome Therapeutics shares, valued at 81.48M$.

Who is the top mutual fund holder of Axsome Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Axsome Therapeutics shares, with 2.69% of its total shares outstanding invested in 1.31M Axsome Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools